Bicara Therapeutics (BCAX) Prepaid Assets (2023 - 2026)
Bicara Therapeutics (BCAX) posted quarterly Prepaid Assets of $5.2 million for Q1 2026, down 40.59% year-over-year from $8.7 million in Q1 2025, and down 28.82% quarter-over-quarter from $7.3 million in Q4 2025.
Bicara Therapeutics (BCAX) Prepaid Assets (2023 - 2026) Analysis & Trends
Bicara Therapeutics' Prepaid Assets history runs 4 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 40.59% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (down 40.59% YoY), while the FY2025 annual figure was $7.3 million, down 43.44% from the prior year.
- Prepaid Assets for Q1 2026 stood at $5.2 million, down from $7.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $12.8 million in Q4 2024, with the low at $633000.0 in Q4 2023.
- The 4-year median for Prepaid Assets is $7.2 million (2025), against an average of $6.3 million.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets surged 1925.59% in 2024, then sank 43.44% in 2025.
- Bicara Therapeutics' Prepaid Assets stood at $633000.0 in 2023, then soared by 1925.59% to $12.8 million in 2024, then plunged by 43.44% to $7.3 million in 2025, then dropped by 28.82% to $5.2 million in 2026.
- Business Quant data shows BCAX's Prepaid Assets at $5.2 million in Q1 2026, $7.3 million in Q4 2025, and $7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Bicara Therapeutics | 1.60 Bn | 1.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.56 Mn |
| Mar 31, 2026 | 5.16 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 7.21 Mn |
| Jun 30, 2025 | 7.79 Mn |
| Mar 31, 2025 | 8.69 Mn |
| Dec 31, 2024 | 12.82 Mn |
| Sep 30, 2024 | 756,000.00 |
| Dec 31, 2023 | 633,000.00 |